Fri.Apr 12, 2024

article thumbnail

Inherited predisposition for higher muscle strength may protect against common morbidities

Science Daily: Pharmacology News

A study showed that a genetic predisposition for higher muscle strength predicts a longer lifespan and a lower risk for developing common diseases. This is a highly comprehensive international study on hereditary muscle strength and its relationship to morbidity. The genome and health data of more than 340,000 Finns was used in the research.

article thumbnail

Chlamydia Vaccine Shows Promise in Early Trial

Drugs.com

FRIDAY, April 12, 2024 -- A chlamydia vaccine has triggered immune responses in an early trial, raising hopes that one day it might help curb the spread of the sexually transmitted infection (STI).There is currently no vaccine for chlamydia, which.

Vaccine 290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bonobos are more aggressive than previously thought

Science Daily: Pharmacology News

Chimpanzees and bonobos are often thought to reflect two different sides of human nature -- the conflict-ready chimpanzee versus the peaceful bonobo -- but a new study shows that, within their own communities, male bonobos are more frequently aggressive than male chimpanzees. For both species, more aggressive males had more mating opportunities.

331
331
article thumbnail

Spike in Measles Cases Could Threaten Elimination Status in U.S.: CDC

Drugs.com

FRIDAY, April 12, 2024 -- More than 100 measles cases have already been reported in the United States this year, a significant increase over previous years that threatens the country's attempts to eliminate the illness, federal health officials.

278
278
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Iconic savanna mammals face genetic problems due to fences and roads

Science Daily: Pharmacology News

Wildebeest migrations have become a rarer sight in Africa as humans continue to interrupt their historic migratory routes with roads, fences, cities, livestock and farmland. This has led to genetic decay in those herds that are no longer able to roam freely, according to new research.

Research 324

More Trending

article thumbnail

Brightest gamma-ray burst of all time came from the collapse of a massive star

Science Daily: Pharmacology News

In 2022, astronomers discovered the brightest gamma-ray burst (GRB) of all time. Now, astronomers confirm that a 'normal' supernova, the telltale sign of a stellar collapse, accompanied the GRB. The team also looked for signatures of heavy elements like gold and platinum in the supernova. They found no evidence of such elements, deepening the mystery of their origins.

317
317
article thumbnail

Parents, You Can Ease a Teen's Stress Around Standardized Tests

Drugs.com

FRIDAY, April 12, 2024 -- Standardized tests put a lot of pressure on teenagers who want to secure their future and make their parents and teachers proud.This stress can lead to symptoms like stomach aches, sleep problems, irritability and.

246
246
article thumbnail

Stellar winds of three sun-like stars detected for the first time

Science Daily: Pharmacology News

An international research team has for the first time directly detected stellar winds from three Sun-like stars by recording the X-ray emission from their astrospheres, and placed constraints on the mass loss rate of the stars via their stellar winds.

article thumbnail

'Virtual Biopsy' Tests Skin Lesions Without a Scalpel

Drugs.com

FRIDAY, April 12, 2024 -- Folks with a suspicious-looking mole or questionable skin lesion often have to endure a scalpel or shaver so their doctor can cut off a sample to send in for biopsy.But a new, noninvasive “virtual biopsy” might soon.

Doctors 246
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Roche, Adaptimmune part ways on cell therapy research

BioPharma Drive: Drug Pricing

The two companies have ended a collaboration that was struck in 2021 and focused on “off-the-shelf” cell therapies for cancer.

Therapies 177
article thumbnail

Pandemic's Effect in Isolating Older Americans May Not Be Over

Drugs.com

FRIDAY, April 12, 2024 -- COVID-19 lockdowns prompted countless American seniors to become socially isolated.Now, new research finds that many have still not fully rejoined society.More than half of older adults still spend more time at home and.

Research 188
article thumbnail

Physicists solve puzzle about ancient galaxy found by Webb telescope

Science Daily: Pharmacology News

Physicists solve a puzzle linked to JWST-ER1g, a massive ancient galaxy that formed when the universe was just a quarter of its current age.

172
172
article thumbnail

European regulator concludes no suicide link to obesity drugs

BioPharma Drive: Drug Pricing

The decision clears a concern hanging over GLP-1 medicines like Ozempic since reports of suicidal ideation and self-harm among people taking the drugs surfaced in July.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New Treatment with Imiquimod Could Be An Advance Against Cervical Precancers

Drugs.com

FRIDAY, April 12, 2024 -- Women who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected. These cells -- called cervical intraepithelial neoplasias (CINs) -- can progress to full-blown.

Treatment 147
article thumbnail

Biotech IPOs bounced back in first quarter, but backlog remains

BioPharma Drive: Drug Pricing

Proceeds from biotech IPOs during the first three months of 2024 matched levels seen in the first quarters of 2019 and 2020, BioPharma Dive data shows.

148
148
article thumbnail

Tips To Getting Your Rosacea Under Control

Drugs.com

FRIDAY, April 12, 2024 -- Rosacea is a common skin condition that causes redness on a person’s face.It commonly appears as a tendency to blush or flush more easily, but also can cause more serious symptoms like:Swollen skin.

130
130
article thumbnail

Optimising CRIPSR gene editing of hard-to-transfect cells

Drug Target Review

Delivery of ribonucleoprotein (RNP) into cells is an essential factor for successful CRISPR gene editing. However, this is difficult to guarantee using traditional CRISPR gene editing methods, especially in hard-to-transfect cells. The standard CRISPR technique involves gathering a group of cells and then electroporating them, using short high-voltage pulses to overcome the barrier of their cell membranes.

article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

New Treatment Could Be Advance Against Cervical Precancers

Drugs.com

FRIDAY, April 12, 2024 -- Women who undergo regular Pap smears are no doubt familiar with the possibility of "precancerous" cells being detected. These cells -- called cervical intraepithelial neoplasias (CINs) -- can progress to full-blown.

Treatment 130
article thumbnail

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

Today’s guest post comes from Jessica Lens, Chief Patient Experience Officer at CareMetx. Jessica discusses the challenges of patient nonadherence. She then outlines how manufacturers can build adherence into their patient services program to increase patient engagement. To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence.

Drugs 98
article thumbnail

Blood Loss Drives Higher Death Rate for Women During Bypass Surgeries

Drugs.com

FRIDAY, April 12, 2024 -- It's long been documented that women have a slimmer chance of surviving heart bypass surgery compared to men, and researchers believe that they now know why.Women tend to be more vulnerable to blood loss during surgery --.

Research 130
article thumbnail

Optimising CRISPR gene editing of hard-to-transfect cells

Drug Target Review

Delivery of ribonucleoprotein (RNP) into cells is an essential factor for successful CRISPR gene editing. However, this is difficult to guarantee using traditional CRISPR gene editing methods, especially in hard-to-transfect cells. The standard CRISPR technique involves gathering a group of cells and then electroporating them, using short high-voltage pulses to overcome the barrier of their cell membranes.

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

Young Women Often Delay Looking Into Breast Symptoms

Drugs.com

FRIDAY, April 12, 2025 -- Young women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks before seeing a doctor about troubling.

Doctors 130
article thumbnail

Unleashing AI in Drug Discovery: Prospects and Challenges

DrugBank

The digital age, mirroring the rapid evolution of the industrial revolution, has ushered in a new era of advancing technology across various sectors, with life sciences and healthcare at its forefront. Over the past decade, the drug discovery landscape has been revolutionized by the adoption of artificial intelligence (AI) and machine learning (ML), witnessing early adopters leapfrog into pioneering technologies aimed at streamlining the drug development process and curtailing associated costs.

Drugs 82
article thumbnail

Draft guidance on potency assays for CGT products garners extensive stakeholder input

Agency IQ

BY RACHEL COE, MSC Late last year, the FDA published a draft update to its 2011 guidance on potency assays for cell and gene therapy products, unveiling a major shift in approach to the issue. Now, the deadline for feedback to that draft guidance has passed, and AgencyIQ has an analysis of the comments here. As defined in statute, the FDA uses the term “potency” to refer to the “specific ability or capability” of a product to “effect a given result.

article thumbnail

Overcoming Payer Challenges With Perficient’s Shop, Quote & Enroll Solution

Perficient: Drug Development

In today’s rapidly evolving healthcare landscape, payers face numerous challenges in delivering efficient and personalized services to their members. The traditional healthcare experience is often fraught with complexities, inefficiencies, and a lack of transparency, leaving both payers and members frustrated. The Challenges: Lack of a Single Member View : Payers often struggle with fragmented member data across various systems, leading to a lack of a unified view of their customers.

article thumbnail

The vote is in: The European Parliament has adopted the compromise pharmaceutical legislation

Agency IQ

BY KIRSTEN MESSMER, PHD, RAC This week, the European Parliament voted to adopt the compromise texts of both the revised pharmaceutical directive and regulation presented by Parliament’s health committee in March 2024. MEP statements during a debate ahead of the vote highlighted alignment on provisions such as regulatory data protection and incentives for antimicrobial research.